CDIO: Cardio Diagnostics Holdings, Inc. Stock

by  •  • Comments Off on CDIO: Cardio Diagnostics Holdings, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 16.58
Enterprise Value ($M) 14.60
Book Value ($M) 3.69
Book Value / Share 0.09
Price / Book 4.50
NCAV ($M) 1.83
NCAV / Share 0.05
Price / NCAV 9.05

Profitability (mra)
Return on Invested Capital (ROIC) -1.87
Return on Assets (ROA) -1.85
Return on Equity (ROE) -2.79

Liquidity (mrq)
Quick Ratio 8.51
Current Ratio 8.51

Balance Sheet (mrq) ($M)
Current Assets 2.63
Assets 4.48
Liabilities 0.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Shares Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-08 13G/A BlackRock, Inc. 4.90 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 227,563 651,545 34.93
2025-03-10 226,418 912,911 24.80
2025-03-07 329,745 857,649 38.45
2025-03-06 439,904 1,269,588 34.65

(click for more detail)

Similar Companies
CAPR – Capricor Therapeutics, Inc. CARA – Cara Therapeutics, Inc.
CASI – CASI Pharmaceuticals, Inc. CDTX – Cidara Therapeutics, Inc.
CDXC – ChromaDex Corporation


Financial data and stock pages provided by
Fintel.io